This is the authors' abstract. We don't add key points for this paper.
A new-type of detection method based on fluorescence probe (CS-βGal) was constructed for efficient and selective mensuration of β-galactosidase (β-Gal). The test method possessed a series of excellent performance, such as a significant fluorescence enhancement (about 11.3-fold), high selectivity as well as superior sensitivity. Furthermore, under the optimal conditions, a relatively low limit of detection down to 0.024 U/mL was achieved for fluorescence titration experiment. It was thanks to the better biocompatibility and low cytotoxicity, CS-βGal had been triumphantly employed to recognize internal and exterior β-Gal concentration varieties in living cells with significant anti-interference performance. Furthermore, the application of CS-βGal in living system was also achieved successfully for monitoring endogenous β-Gal enzyme activity.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: